0 Ratings

ID

34603

Description

Performance of a Tablet Based Workflow and Decision Support System With Incorporated Software Algorithm Used for Glycaemic Management; ODM derived from: https://clinicaltrials.gov/show/NCT01766752

Link

https://clinicaltrials.gov/show/NCT01766752

Keywords

  1. 1/19/19 1/19/19 -
  2. 4/17/20 4/17/20 -
  3. 4/17/20 4/17/20 - Sarah Riepenhausen
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 19, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility Type 2 Diabetes NCT01766752

    Eligibility Type 2 Diabetes NCT01766752

    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693 (Inclusion)
    informed consent obtained after being advised of the nature of the study
    Description

    ID.1

    Data type

    boolean

    male or female aged 18 - 90 years (both inclusive)
    Description

    ID.2

    Data type

    boolean

    type 2 diabetes treated with diet, oral agents, non-insulin injected anti-diabetic medicine, insulin therapy or any combination of the four
    Description

    ID.3

    Data type

    boolean

    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251 (Exclusion Criteria)
    impaired renal function (serum creatinine ≥3.0mg/dl)
    Description

    ID.4

    Data type

    boolean

    any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient
    Description

    ID.5

    Data type

    boolean

    pregnancy
    Description

    ID.6

    Data type

    boolean

    any mental condition rendering the patient incapable of giving his consent
    Description

    ID.7

    Data type

    boolean

    terminally ill patients
    Description

    ID.8

    Data type

    boolean

    participation in a trial within 3 months prior to this trial
    Description

    ID.9

    Data type

    boolean

    known or suspected allergy to insulin
    Description

    ID.10

    Data type

    boolean

    Similar models

    Eligibility Type 2 Diabetes NCT01766752

    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    C1512693 (UMLS CUI)
    ID.1
    Item
    informed consent obtained after being advised of the nature of the study
    boolean
    ID.2
    Item
    male or female aged 18 - 90 years (both inclusive)
    boolean
    ID.3
    Item
    type 2 diabetes treated with diet, oral agents, non-insulin injected anti-diabetic medicine, insulin therapy or any combination of the four
    boolean
    Item Group
    C0680251 (UMLS CUI)
    ID.4
    Item
    impaired renal function (serum creatinine ≥3.0mg/dl)
    boolean
    ID.5
    Item
    any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient
    boolean
    ID.6
    Item
    pregnancy
    boolean
    ID.7
    Item
    any mental condition rendering the patient incapable of giving his consent
    boolean
    ID.8
    Item
    terminally ill patients
    boolean
    ID.9
    Item
    participation in a trial within 3 months prior to this trial
    boolean
    ID.10
    Item
    known or suspected allergy to insulin
    boolean

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial